Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Dr. Reddy's Laboratories Limited (RDY)

37.74 -0.33 (-0.87%)

12-07 16:02

Open:

38.24

Pre. Close:

38.07

High:

38.36

Low:

37.705

Volume:

270,873

Market Cap:

6341M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

38.406 - 38.646

38.646 - 38.815

Low:

37.136 - 37.438

37.438 - 37.651

Close:

37.346 - 37.785

37.785 - 38.095

Technical analysis  (as of: 2018-12-07 5:32:22 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 45.60     One year: 53.26

Support:

Support1: 34.93    Support2: 32.39

Resistance:

Resistance1: 39.04    Resistance2: 45.60

Pivot:

36.95

Moving Averages:

MA(5): 38.19     MA(20): 36.15

MA(100): 34.08     MA(250): 33.73

MACD:

MACD(12,26): 1.12     Signal(12,26,9): 0.96

%K %D:

%K(14,3): 81.41     %D(3): 85.18

RSI:

RSI(14): 63.33

52-Week:

High: 39.96  Low: 28.13  Change(%): 10.3

Average Vol(K):

3-Month: 28638  10-Days 29063

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
RDY has closed below upper band by 34.2%. Bollinger Bands are 23.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-11-28T03:20:00-05:00
Dr. Reddy's Laboratories Announces the Launch of Chlorthalidone Tablets, USP in the U.S. Market

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Specialty Generic

Shares Out. (M)

166.05

Shares Float (M)

166.05

% Held by Insiders

% Held by Institutions

6.10

Shares Short (K)

1537

Shares Short Prior Month (K)

Stock Financials

EPS

1.020

EPS Est. Current Year

1.200

EPS Est. Next Year

1.810

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

3.410

PEG Ratio

Profit Margin

10.69

Operating Margin

11.75

Return on Assets (ttm)

6.7

Return on Equity (ttm)

12.1

Qtrly Rev. Growth

7.1

Gross Profit (p.s.)

2.020

Sales Per Share

EBITDA (p.s.)

0.857

Qtrly Earnings Growth

76.80

Operating Cash Flow (M)

277.88

Levered Free Cash Flow (M)

75.58

Valuation

P/E

37.00

P/E Growth Ratio

-0.01

P/BV

11.07

P/S

478510944.00

P/CF

22.55

Dividend Yield

0.02

Dividends & Splits

Dividend

0.760

Dividend Pay Date

2018-08-09

Ex-Dividend Date

2018-07-13

Forward Dividend

0.290

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.